Categories AlphaGraphs, Earnings, Technology

Earnings: Danaher Corporation (DHR) Q2 2023 sales and profit decline

Technology company Danaher Corporation (NYSE: DHR) reported lower sales and net profit for the second quarter of 2023.

Danaher Corporation Q2 2023 earnings infographic

Second-quarter net income was $1.11 billion, or $1.49 per share, compared to $1.66 billion or $2.25 per share in the same period of last year. Adjusted earnings decreased 25% year-over-year to $2.05 per share.

The bottom line was hurt by an 8% fall in net sales to $7.16 billion, mainly due to lower sales in the Diagnostics and Biotechnology segments.

Prior Performance

  • Danaher Corporation Q4 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report

Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,

J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights

The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top